4+7带量采购执行细则将出台 明年3月落地

2018-12-21 焦萌萌 、 洪杰 医药地理

12月20日,上海集中采购事务管理所召开4+7国家带量采购会议,国家医疗保障局副局长陈金甫、十一省市负责招采工作的领导,以及中标企业代表参会。

12月20日,上海集中采购事务管理所召开4+7国家带量采购会议,国家医疗保障局副局长陈金甫、十一省市负责招采工作的领导,以及中标企业代表参会。

据了解,会议主要传达了三个重点:

1、各区域集采部门表态做好政策的落地,企业表态保证产能与质量;

2、大约在本月下旬或2019年上旬,国家会出台具体执行细则,地方在1月中旬出台地方执行细则,具体执行细则陆续出台;

3、要求各区域要在2019年3月15日前全部落地,上海会先执行;

4、国家月底前会出医保支付标准指导文件,梯度降幅据说会参照此标准。

“4+7”带量采购工作进展时间轴

11月14日

在中共中央总书记、国家主席、中央军委主席、中央全面深化改革委员会主任习近平主持召开中央全面深化改革委员会第五次会议上,审议通过了《国家组织药品集中采购试点方案》。

11月15日

联合采购办公室正式发布《4+7城市药品集中采购文件》,确定了国家组织药品集中采购试点范围为北京、天津、上海、重庆和沈阳、大连、厦门、广州、深圳、成都、西安11个城市,并公布了31个采购品种(指定规格)及各试点地区约定采购量。

11月21日

上海市医药集中招标采购事务管理所发布《4+7城市药品集中采购上海地区补充文件》。就上海地区企业申报、药品配送、质量检测、三方协议、货款支付、中选品种使用等内容发布了实施细则。

12月7日

国务院召开国家组织药品集中采购和使用试点启动部署会,并确认了拟中选结果,正式对外进行为期一周的公示,这标志着此项工作进入实施阶段。根据公示,31个试点通用名药品有25个集中采购拟中选,与试点城市2017年同种药品最低采购价相比,拟中选价平均降幅52%,最高降幅96%。

孙春兰出席会议并讲话,强调要坚持市场机制和政府作用相结合,探索跨区域联盟集中带量采购,量价挂钩、招采合一,做好保证使用、确保质量、稳定供应、及时回款等工作,促进药价回归合理水平、药品行业实现转型升级。国家组织药品集中采购试点办、联合采购办公室负责人就有关问题接受了记者采访。

同日, 上海阳光医药采购网公示4+7城市药品集中采购拟中选结果上海地区配送企业。

12月14日

上海药事所邀请中标企业代表参加现场“4+7”会议,明确一系列中选后执行问题。

12月17日

联合采购办公室开展了药品集中采购工作,并公布了《4+7城市药品集中采购中选品种表》和《4+7城市药品集中采购中选后供应品种清单》。

12月20日

上海集中采购事务管理所召开国家组织药品集中采购试点工作会议。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1941138, encodeId=07db1941138e4, content=<a href='/topic/show?id=1a5213229f' target=_blank style='color:#2F92EE;'>#4+7带量采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1322, encryptionId=1a5213229f, topicName=4+7带量采购)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Tue Nov 26 20:14:00 CST 2019, time=2019-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356926, encodeId=a3683569263a, content=带量釆购执行细则。, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Jan 01 19:32:30 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398775, encodeId=b9bd1398e7580, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1316, encryptionId=794413168f, topicName=4+7)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Sun Dec 23 08:14:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532792, encodeId=09b71532e92b7, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Sun Dec 23 08:14:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356136, encodeId=af9d3561366f, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Dec 22 23:35:40 CST 2018, time=2018-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356104, encodeId=c84035610451, content=明年执行釆购细则。, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 22 18:13:59 CST 2018, time=2018-12-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1941138, encodeId=07db1941138e4, content=<a href='/topic/show?id=1a5213229f' target=_blank style='color:#2F92EE;'>#4+7带量采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1322, encryptionId=1a5213229f, topicName=4+7带量采购)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Tue Nov 26 20:14:00 CST 2019, time=2019-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356926, encodeId=a3683569263a, content=带量釆购执行细则。, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Jan 01 19:32:30 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398775, encodeId=b9bd1398e7580, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1316, encryptionId=794413168f, topicName=4+7)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Sun Dec 23 08:14:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532792, encodeId=09b71532e92b7, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Sun Dec 23 08:14:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356136, encodeId=af9d3561366f, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Dec 22 23:35:40 CST 2018, time=2018-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356104, encodeId=c84035610451, content=明年执行釆购细则。, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 22 18:13:59 CST 2018, time=2018-12-22, status=1, ipAttribution=)]
    2019-01-01 jyzxjiangqin

    带量釆购执行细则。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1941138, encodeId=07db1941138e4, content=<a href='/topic/show?id=1a5213229f' target=_blank style='color:#2F92EE;'>#4+7带量采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1322, encryptionId=1a5213229f, topicName=4+7带量采购)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Tue Nov 26 20:14:00 CST 2019, time=2019-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356926, encodeId=a3683569263a, content=带量釆购执行细则。, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Jan 01 19:32:30 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398775, encodeId=b9bd1398e7580, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1316, encryptionId=794413168f, topicName=4+7)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Sun Dec 23 08:14:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532792, encodeId=09b71532e92b7, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Sun Dec 23 08:14:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356136, encodeId=af9d3561366f, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Dec 22 23:35:40 CST 2018, time=2018-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356104, encodeId=c84035610451, content=明年执行釆购细则。, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 22 18:13:59 CST 2018, time=2018-12-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1941138, encodeId=07db1941138e4, content=<a href='/topic/show?id=1a5213229f' target=_blank style='color:#2F92EE;'>#4+7带量采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1322, encryptionId=1a5213229f, topicName=4+7带量采购)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Tue Nov 26 20:14:00 CST 2019, time=2019-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356926, encodeId=a3683569263a, content=带量釆购执行细则。, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Jan 01 19:32:30 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398775, encodeId=b9bd1398e7580, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1316, encryptionId=794413168f, topicName=4+7)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Sun Dec 23 08:14:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532792, encodeId=09b71532e92b7, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Sun Dec 23 08:14:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356136, encodeId=af9d3561366f, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Dec 22 23:35:40 CST 2018, time=2018-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356104, encodeId=c84035610451, content=明年执行釆购细则。, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 22 18:13:59 CST 2018, time=2018-12-22, status=1, ipAttribution=)]
    2018-12-23 wolongzxh
  5. [GetPortalCommentsPageByObjectIdResponse(id=1941138, encodeId=07db1941138e4, content=<a href='/topic/show?id=1a5213229f' target=_blank style='color:#2F92EE;'>#4+7带量采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1322, encryptionId=1a5213229f, topicName=4+7带量采购)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Tue Nov 26 20:14:00 CST 2019, time=2019-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356926, encodeId=a3683569263a, content=带量釆购执行细则。, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Jan 01 19:32:30 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398775, encodeId=b9bd1398e7580, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1316, encryptionId=794413168f, topicName=4+7)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Sun Dec 23 08:14:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532792, encodeId=09b71532e92b7, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Sun Dec 23 08:14:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356136, encodeId=af9d3561366f, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Dec 22 23:35:40 CST 2018, time=2018-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356104, encodeId=c84035610451, content=明年执行釆购细则。, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 22 18:13:59 CST 2018, time=2018-12-22, status=1, ipAttribution=)]
    2018-12-22 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1941138, encodeId=07db1941138e4, content=<a href='/topic/show?id=1a5213229f' target=_blank style='color:#2F92EE;'>#4+7带量采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1322, encryptionId=1a5213229f, topicName=4+7带量采购)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Tue Nov 26 20:14:00 CST 2019, time=2019-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356926, encodeId=a3683569263a, content=带量釆购执行细则。, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Jan 01 19:32:30 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398775, encodeId=b9bd1398e7580, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1316, encryptionId=794413168f, topicName=4+7)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Sun Dec 23 08:14:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532792, encodeId=09b71532e92b7, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Sun Dec 23 08:14:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356136, encodeId=af9d3561366f, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Dec 22 23:35:40 CST 2018, time=2018-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356104, encodeId=c84035610451, content=明年执行釆购细则。, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 22 18:13:59 CST 2018, time=2018-12-22, status=1, ipAttribution=)]
    2018-12-22 jyzxjiangqin

    明年执行釆购细则。

    0

相关资讯

带量采购仅是小试牛刀 医药产业链将彻底重构!

估计新的一期国家带量采购已是箭在弦上,基本上国家局两次定下基调,整个医药产业将彻底重构。

医保带量采购挤压处方药零售

随着医保带量采购的推开,部分分析认为处方药开发零售市场将成为下一步发展的重点。但从市场趋势来看,医院内药价断崖式下跌将对药品零售市场形成很大的冲击,尤其是对寄希望于处方外流的零售渠道形成较大的影响,零售市场很难成为高价原研药和其他仿制药的救命稻草。

2019年医药代表要大裁员?

这不单是一个优胜劣汰的时代,这更是一个无差别攻击的时代。想淘汰过剩产能,减少同类产品过多的情况,同时减少临床上辅助药过度使用情况,医疗行业在非常时期用了非常手段。 药物一致性评价、11城市带量采购、全国辅助用药目录每一项政策都如落地惊雷,影响着行业的走向,每一个政策可能都是一次市场格局洗牌的机会。外企,国企,大包,谁都无法独善其身,而作为这些公司一线的销售,公司的命运就是自己的职业命运。

4+7价格全国联动!安徽山东四川要动手

开始了,4+7带量采购,山东、四川、安徽等省市,价格要联动! ▍4+7价格联动,安徽、山东、四川要动手 近日,有业内人透露,安徽要开始对“4+7”中标品种议价了。模式和“4+7”类似,给出“80%采购量”,要求医院必须确保带量采购产品的80%采购量,如果医院执行过程中有问题,药企可以直接向有关方面投诉。

带量采购将挤压民营医疗 基层冲击很大

医保带量采购虽然已经揭晓,但部分市场观点认为没有触及服务改革。不过,医保带量采购对于以医保为主要收入的民营医疗机构事实上将产生很大的挤压,民营医疗机构急需转型。

**降幅96%!“4+7”带量采购报价流出,这些药代要凉了

昨日(12月6日),4+7城市拟中标结果在业界疯传。价格降幅之大,令人大跌眼镜。